Is It Time for a New Taxonomy for Heart Failure?

Journal of Cardiac Failure

Volumn 22, Issue 9, 2016, Pages 710-712

  Mann, Douglas L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; BIOLOGICAL MARKER; ERBB4 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE;

AFRICAN AMERICAN; CAUCASIAN; DIASTOLIC HEART FAILURE; EDITORIAL; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAN CHINESE; HEART FAILURE; HEART FAILURE WITH A REDUCED EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC HEART FAILURE; TAXONOMY; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CLASSIFICATION; FEMALE; GENETICS; HEART STROKE VOLUME; MALE; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CLASSIFICATION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; RECEPTOR, ERBB-4; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME;

EID: 84990938384     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.07.432     Document Type: Editorial

References (10)

1. 1 Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E. Jr, Drazner, M.H., et al. 2013 ACCF/AHA Guideline for the Management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128 (2013), e240–327.
2. 2 Cressy, W.L., Manual of the international list of causes of death, based on the Second decennial revision by the International commission, Paris, July 1 to 3, 1909. In: Census USBot, editor. 1913: United States. Bureau of the Census, 1911.
3. 3 Monsour, I.N., Bress, A.P., Groo, V., Ismail, S., Wu, G., Patel, S., et al. Circulating procollage type III N-terminal peptide and mortality risk in african americans with heart failure. J Card Fail 22 (2016), 692–699.
4. 4 Wang, Y., Zhang, Y., An, T., Zhang, R., Zhao, X., Liu, N., et al. ErbB4 polymorphism is asosociated with the risk and prognosis of congestive heart failure in the northern Han chinese population. J Card Fail 22 (2016), 700–709.
5. 5 Council, N.R., Toward precision medicine: building a knowledge networkfor biomedical research and a new taxonomy of disease. 2011, National Academies Press, Washington, DC.
6. 6 Hofmann-Apitius, M., Alarcón-Riquelme, M.E., Chamberlain, C., McHale, D., Towards reforming the taxonomy of human disease. Nat Rev Drug Discov, 14, 2015, 2.
7. 7 Coalition, P.M., Progress Report: Personalized Medicine at FDA. Available at: http://www.personalizedmedicinecoalition.org/News/Press_Releases/More_Than_1_in_4_Novel_New_Drugs_Approved_by_FDA_in_2015_are_Personalized_Medicines2015, 2015.
8. 8 Obama, B., The Precision Medicine Initiative. Available at: https://www.whitehouse.gov/precision-medicine.
9. 9 Trans-Omics for Precision Medicine (TOPMed) Program. Available at: http://www.nhlbi.nih.gov/research/resources/nhlbi-precision-medicine-initiative/topmed.
10. 10 FDA's Role in the Precision Medicine Initiative. Available at: http://www.fda.gov/ScienceResearch/SpecialTopics/PrecisionMedicine/default.htm.